Back to Results
First PageMeta Content
Trastuzumab / HER2/neu / Biology / Breast cancer / Management of cancer / Predictive marker / Breast cancer chemotherapy / Ribbon symbolism / Medicine / Cancer treatments


Public Summary Document Application No. 1230 – HER2 ISH testing for access to trastuzumab for neoadjuvant breast cancer Applicant: Roche Products Pty Ltd Australia Date of MSAC consideration: 2 August 2012
Add to Reading List

Document Date: 2014-11-06 23:49:40


Open Document

File Size: 48,85 KB

Share Result on Facebook
UPDATE